drugset / Trial / NCT00471068

Study of Travatan and Cosopt in Primary Open-Angle Glaucoma or Ocular Hypertension

NCT00471068

Phase 4 Terminated 46 enrolled Alcon Research
RandomizedParallel-groupDouble-blindTreatment

Summary

To compare the efficacy and safety in patients treated with travoprost versus dorzolamide/timolol maleate combination in patients with open-angle glaucoma or ocular hypertension

Timeline

Start
2007-03
Primary completion
2008-08
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Dorzolamide Small molecule 20 mg/ml Other
Comparator Timolol Other / unclassified 5 mg/ml Other
Subject Travoprost Other / unclassified 40 mg/ml Other